DocSym
β
Searchsearch
Search
(D02.2) Carcinoma in situ: bronchus and lung
More details coming soon
45 605 in individuals diagnosis carcinoma in situ: bronchus and lung confirmed
6 065 deaths with diagnosis carcinoma in situ: bronchus and lung
13% mortality rate associated with the disease carcinoma in situ: bronchus and lung
Diagnosis carcinoma in situ: bronchus and lung is diagnosed Men are 42.27% more likely than Women
32 442
Men receive the diagnosis carcinoma in situ: bronchus and lung
792 (2.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
13 163
Women receive the diagnosis carcinoma in situ: bronchus and lung
5 273 (40.1 %)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: bronchus and lung - Men aged 60-64 and Women aged 55-59
In Men diagnosis is most often set at age 0-9, 15-29, 40-94
Less common in men the disease occurs at Age 0-1, 10-14, 30-39, 95+Less common in women the disease occurs at Age 0-1, 5-9, 30-39, 90-95+
In Women diagnosis is most often set at age 0-5, 10-29, 40-89
Disease Features carcinoma in situ: bronchus and lung
Absence or low individual and public risk
Carcinoma in situ: bronchus and lung - what does this mean
Carcinoma in situ of the bronchus and lung occurs when abnormal cells begin to grow in the lining of the bronchial tubes and lungs, but have not yet spread beyond the layer of tissue in which they began. these cells appear to be cancerous, but have not yet invaded other parts of the body.
What happens during the disease - carcinoma in situ: bronchus and lung
Carcinoma in situ of the bronchus and lung is caused by long-term exposure to carcinogenic agents such as tobacco smoke, air pollutants, and radiation. this exposure leads to the accumulation of genetic damage in the cells of the bronchus and lung, which can lead to uncontrolled cell growth and the development of cancer.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Imaging studies such as X-ray, CT scan, and MRI
- Bronchoscopy to collect tissue samples for biopsy
- Bronchial lavage to collect fluid samples for cytology
- Bronchial brushing to collect cells for biopsy
- Endobronchial ultrasound to guide tissue sampling
- Thoracoscopy to collect tissue samples for biopsy
- Thoracentesis to collect fluid samples for cytology
Treatment and Medical Assistance
Main goal of the Treatment: To eradicate the carcinoma in situ in the bronchus and lung.
- Perform a bronchoscopy to obtain a biopsy of the affected area.
- Administer chemotherapy and/or radiation therapy.
- Perform a lobectomy (surgical removal of the affected lobe of the lung).
- Perform a pneumonectomy (surgical removal of the entire lung).
- Perform a mediastinoscopy (surgical procedure to examine the mediastinum).
- Administer targeted therapy (e.g. anti-angiogenic drugs).
- Administer immunotherapy (e.g. monoclonal antibodies).
- Perform a thoracoscopy (surgical procedure to examine the chest cavity).
- Administer hormone therapy (e.g. anti-estrogen drugs).
- Perform a pleurodesis (surgical procedure to prevent pleural effusions).
- Administer gene therapy (e.g. gene-modified T-cells).
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: bronchus and lung - Prevention
Carcinoma in situ of the bronchus and lung can be prevented by avoiding smoking, reducing exposure to environmental pollutants, exercising regularly, eating a balanced diet, and maintaining a healthy weight.